Charcot-Marie-Tooth disease type 1A (CMT1A) and hereditary neuropathy with liability to pressure palsies (HNPP):: Reliable detection of the CMT1A duplication and HNPP deletion using 8 microsatellite markers in 2 multiplex PCRs

被引:0
|
作者
Seeman, P
Mazanec, R
Zidar, J
Hrusáková, S
Ctvrtecková, M
Rautenstrauss, B
机构
[1] Charles Univ, Sch Med 2, Dept Child Neurol, Prague 15006 5, Czech Republic
[2] Charles Univ, Sch Med 2, Dept Neurol, Prague 15006 5, Czech Republic
[3] Univ Ljubljana, Med Ctr, Inst Child Neurophysiol, Ljubljana 61105, Slovenia
[4] Univ Erlangen Nurnberg, Dept Human Genet, D-91054 Erlangen, Germany
关键词
Charcot-Marie-Tooth type 1; hereditary neuropathy with liability to pressure palsies; hereditary motor and sensory neuropathies; microsatellite markers; multiplex PCR; fragment analysis;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Charcot-Marie-Tooth disease (CMT) and hereditary neuropathy with liability to pressure palsies (HNPP) are the most frequent inherited disorders of the peripheral nervous system. They are clinically and genetically heterogeneous. A submicroscopic tandem duplication of 1.5 Mb in chromosome 17p11.2-12 comprising the PMP22 gene is found in 70.7% of autosomal dominant Charcot-Marie-Tooth type 1 (CMT1) patients. A reciprocal deletion is found in 87.6% of HNPP patients. The size of the typical CMT1A duplication is too small for classical cytogenetics and the whole region including the CMT1A-REP elements is sometimes too complex for a single DNA analysis method. We present results of a multiplex PCR of 8 microsatellite markers with multicolour fluorescence primer labelling followed by fragment analysis on an ABI 310 Prism analyzer to simplify the diagnostic procedure. Results for 24 patients can be obtained within 24 h. This method was applied on 92 DNA samples of unrelated patients carrying a typical CMT1A duplication previously confirmed by two colour fluorescence ii situ hybridization (FISH, probe c132G8) and EcoRI/SacI Southern blotting (probe pLR7.8). Three alleles of three different sizes were clearly detected at least once in 88 of them (95.6%). Subsequently this analysis was applied on 312 Czech patients and revealed a CMT1A/HNPP rearrangement in 109 out of them.
引用
收藏
页码:421 / 426
页数:6
相关论文
共 50 条
  • [21] Unmasking a Case of Asymptomatic Charcot-Marie-Tooth Disease (CMT1A) With Vincristine
    Jariwal, Roopam
    Shoua, Basel
    Sabetian, Katayoun
    Natarajan, Piruthiviraj
    Cobos, Everardo
    JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2018, 6
  • [22] CHARCOT-MARIE-TOOTH DISEASE 1A (CMT1A) ASSOCIATED WITH A MATERNAL DUPLICATION OF CHROMOSOME-17P11.2-]12
    UPADHYAYA, M
    ROBERTS, SH
    FARNHAM, J
    MACMILLAN, JC
    CLARKE, A
    HEATH, JP
    HODGES, ICG
    HARPER, PS
    HUMAN GENETICS, 1993, 91 (04) : 392 - 394
  • [23] PRENATAL-DIAGNOSIS OF CHARCOT-MARIE-TOOTH DISEASE TYPE 1A (CMT1A) USING MOLECULAR-GENETIC TECHNIQUES
    NAVON, R
    TIMMERMAN, V
    LOFGREN, A
    LIANG, P
    NELIS, E
    ZEITUNE, M
    Van Broeckhoven, C
    PRENATAL DIAGNOSIS, 1995, 15 (07) : 633 - 640
  • [24] Vestibular impairment in Charcot-Marie-Tooth type 1A and Hereditary Neuropathy with Liability to Pressure Palsies
    Calic, Z.
    Bjelica, B.
    Peric, S.
    Vujnic, M.
    Bozovic, I.
    Rakocevic-Stojanovic, V.
    Welgampola, M.
    Bradshaw, A.
    Welgampola, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 426 - 426
  • [25] ESTIMATION OF THE SIZE OF THE CHROMOSOME 17P11.2 DUPLICATION IN CHARCOT-MARIE-TOOTH NEUROPATHY TYPE-1A (CMT1A)
    RAEYMAEKERS, P
    TIMMERMAN, V
    NELIS, E
    VANHUL, W
    DE JONGHE, P
    MARTIN, JJ
    VANBROECKHOVEN, C
    CEUTERICK, C
    DEWINTER, G
    DENAYER, P
    GHEUENS, J
    JACOBS, K
    MERCELIS, R
    RAES, G
    RINGOET, K
    SMEYERS, G
    SWERTS, L
    VAN DENBERGHE, A
    VANHAERINGEN, A
    VERELLENDUMOULLIN, C
    JOURNAL OF MEDICAL GENETICS, 1992, 29 (01) : 5 - 11
  • [26] The use of remote measures for charcot marie tooth type 1A (CMT1A), a pilot study
    Baker, Lindsay
    Charles, Julie
    Behrens-Spraggins, Steffen
    Sowden, Janet
    Wood, Elizabeth
    Hermann, David
    Eichinger, Katy
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2021, 26 (03) : 423 - 423
  • [27] Synergy of baclofen, naltrexone and sorbitol (PXT3003) in Charcot-Marie-Tooth Type 1A (CMT1A)
    Laffaire, Julien
    Rinaudo, Philippe
    Bertrand, Viviane
    Schmitt, Peter
    Goedkoop, Rene
    Cohen, Daniel
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2018, 23 (04) : 335 - 335
  • [28] Hereditary neuropathy with liability to pressure palsies with a partial deletion of the region often duplicated in Charcot-Marie-Tooth disease, type 1A
    Chapon, F
    Diraison, P
    Lechevalier, B
    Chazot, G
    Viader, F
    Bonnebouche, C
    Vandenberghe, A
    Timmerman, V
    Van Broeckhoven, C
    Vandenberghe, A
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1996, 61 (05): : 535 - 536
  • [29] DELETION IN THE CMT1A LOCUS ON CHROMOSOME 17P11.2 IN HEREDITARY NEUROPATHY WITH LIABILITY TO PRESSURE PALSIES
    VERHALLE, D
    LOFGREN, A
    NELIS, E
    DEHAENE, I
    THEYS, P
    LAMMENS, M
    DOM, R
    VAN BROECKHOVEN, C
    ROBBERECHT, W
    ANNALS OF NEUROLOGY, 1994, 35 (06) : 704 - 708
  • [30] Quality of life in hereditary neuropathy with liability to pressure palsies is as impaired as in Charcot-Marie-Tooth disease type 1A
    Bjelica, B.
    Peric, S. Z.
    Bozovic, I.
    Basta, I.
    Kacar, A.
    Jankovic, M.
    Brankovic, M.
    Palibrk, A.
    Novakovic, I.
    Lavrnic, D.
    Stevic, Z.
    Stojanovic, V. Rakocevic
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 400 - 400